Semler Scientific (NASDAQ:SMLR) Shares Gap Down – Here’s Why

Shares of Semler Scientific, Inc. (NASDAQ:SMLR) gapped down prior to trading on Tuesday . The stock had previously closed at $60.71, but opened at $58.32. Semler Scientific shares last traded at $60.81, with a volume of 192,941 shares trading hands.

Semler Scientific Stock Up 4.1 %

The company has a 50 day simple moving average of $36.60 and a 200 day simple moving average of $32.36. The stock has a market cap of $523.85 million, a price-to-earnings ratio of 29.61 and a beta of 1.17.

Semler Scientific (NASDAQ:SMLR) last released its quarterly earnings results on Monday, November 4th. The company reported $0.72 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.37 by $0.35. Semler Scientific had a return on equity of 20.31% and a net margin of 27.00%. The business had revenue of $13.51 million during the quarter.

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of the business. State Street Corp lifted its position in Semler Scientific by 0.6% during the third quarter. State Street Corp now owns 118,223 shares of the company’s stock valued at $2,784,000 after purchasing an additional 725 shares during the period. CWM LLC lifted its stake in shares of Semler Scientific by 486.3% in the 2nd quarter. CWM LLC now owns 897 shares of the company’s stock worth $31,000 after purchasing an additional 744 shares during the period. Quest Partners LLC boosted its holdings in shares of Semler Scientific by 48.0% in the third quarter. Quest Partners LLC now owns 2,520 shares of the company’s stock worth $59,000 after buying an additional 817 shares during the last quarter. Newbridge Financial Services Group Inc. bought a new stake in Semler Scientific during the second quarter valued at approximately $34,000. Finally, US Bancorp DE increased its holdings in Semler Scientific by 60.8% during the third quarter. US Bancorp DE now owns 3,064 shares of the company’s stock valued at $72,000 after buying an additional 1,158 shares during the last quarter. Hedge funds and other institutional investors own 49.37% of the company’s stock.

About Semler Scientific

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition.